Monoclonal antibodies specific for neoplasia-specific NADH:disulfide reductase
US7053188B2 · kind B2 · utility
8Cited by
26References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 24, 2003 |
| Grant date | May 30, 2006 |
| Priority date | — |
| Expiry date | May 5, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods for diagnosis of neoplastic tissue are described. Monoclonal antibodies which specifically recognize the tumor cell specific NADH:protein thiol reductase and the hybridoma cell lines which produce them are provided. Also provided are diagnostic and immunohistological assays for the identification of cells that are neoplastic.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.